- Home
- CNTA vs RHI Comparison
CNTA vs RHI Comparison
Compare CNTA & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | RHI |
|---|---|---|
| Founded | 2020 | 1948 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.3B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTA | RHI |
|---|---|---|
| Price | $25.33 | $27.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 6 |
| Target Price | ★ $37.70 | $36.00 |
| AVG Volume (30 Days) | 1.3M | ★ 1.7M |
| Earning Date | 11-05-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 8.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.54 |
| Revenue | $15,000,000.00 | ★ $5,458,499,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.94 |
| P/E Ratio | ★ N/A | $17.99 |
| Revenue Growth | ★ 118.88 | N/A |
| 52 Week Low | $9.60 | $25.22 |
| 52 Week High | $30.58 | $72.31 |
Technical Indicators
Market Signals| Indicator | CNTA | RHI |
|---|---|---|
| Relative Strength Index (RSI) | 42.85 | 50.40 |
| Support Level | $24.17 | $27.01 |
| Resistance Level | $26.01 | $28.46 |
| Average True Range (ATR) | 1.20 | 0.77 |
| MACD | -0.37 | 0.07 |
| Stochastic Oscillator | 19.03 | 51.75 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.